Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

United Therapeutics Corp (NASDAQ:UTHR)

105.92
Delayed Data
As of Jun 30
 +2.38 / +2.30%
Today’s Change
97.52
Today|||52-Week Range
181.03
-32.37%
Year-to-Date
No recent news for United Therapeutics Corp.

Today’s Trading

Previous close103.54
Today’s open103.76
Day’s range103.30 - 106.09
Volume657,384
Average volume (3 months)728,248
Market cap$4.5B
Dividend yield--
Data as of 06/30/2016

Growth & Valuation

Earnings growth (last year)+102.55%
Earnings growth (this year)+8.87%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+13.76%
P/E ratio6.1
Price/Sales5.47
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
OPKOPKO Health Inc+0.04+0.43%
GRFSGrifols SA+0.78+4.91%
NBIXNeurocrine Bioscienc...+0.06+0.13%
ICPTIntercept Pharmaceut...-7.19-4.80%
Data as of 06/30/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$3.10
Annual revenue (last year)$1.5B
Annual profit (last year)$651.6M
Net profit margin44.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts

Partner Offers

Search for Jobs